Leap Therapeutics (LPTX) Revenue (2013 - 2025)
Leap Therapeutics (LPTX) revenue from Mar 31, 2013 to Jun 30, 2025. The TTM Leap Therapeutics (LPTX) revenue is $10K. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Leap Therapeutics (LPTX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -98.41% |
| 3 Years TTM | -76.39% |
| 5 Years TTM | -57.94% |
Annual Revenue change of Leap Therapeutics (LPTX)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $0 | N/A |
| 2024 | $0 | N/A |
| 2023 | $0 | -100.00% |
| 2022 | $380K | -74.67% |
| 2021 | $1.50M | N/A |
| 2020 | $1.50M | +294.74% |
| 2019 | $380K | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
Comparison Leap Therapeutics (LPTX) five years revenue CAGR with competitors
Leap Therapeutics (LPTX) five years revenue CAGR is -57.83%.